Solute carrier organic anion transporter family member 1B1

Target ID: CHEMBL1697668

Organism: Homo sapiens

Type: SINGLE PROTEIN

View on ChEMBL

Molecules

Name SMILES Bioactivity Structure
METHOTREXATE CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1 ID50: 6.2 nM
GENISTEIN O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12 IC50: 1000.0 nM
FUROSEMIDE NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl Ki: 100000.0 nM
FLUVASTATIN CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21 IC50: 28.0 nM
HYDROXYPROGESTERONE CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C Remaining activity: 89.0 %
MIFEPRISTONE CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C IC50: 0.028 nM
ERLOTINIB C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1 IC50: 1450.0 nM
AMITRAZ Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1 Potency: 0.9 nM
ROSUVASTATIN CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O Ki: 0.9 nM
AMPRENAVIR CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1 Ki: 0.16 nM
AMITRIPTYLINE CN(C)CCC=C1c2ccccc2CCc2ccccc21 IC50: 61.0 nM
ATENOLOL CC(C)NCC(O)COc1ccc(CC(N)=O)cc1 Pc: 1000000.0 cm s-1
THEOPHYLLINE Cn1c(=O)c2[nH]cnc2n(C)c1=O ED50: 18.5 mg.kg-1
FLUCONAZOLE OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F IC80: 2.8 ug ml-1
CANDESARTAN CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1 T1/2: 9.0 hr
TOPIRAMATE CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1 Ki: 250.0 nM
DIETHYLSTILBESTROL CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 EC50: 9.0 nM
GLYCYRRHIZIN CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12 Protection: 15.0 %
AMOXICILLIN CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O MIC: 0.021 ug.mL-1
ASTEMIZOLE COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1 Binding energy: 11.3 kCal mol-1
CAFFEINE Cn1c(=O)c2c(ncn2C)n(C)c1=O Vdss: 0.61 L.kg-1
QUERCETIN O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 IC50: 32870.0 nM
LEVODOPA N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O IC50: 900000.0 nM
DAIDZEIN O=c1c(-c2ccc(O)cc2)coc2cc(O)ccc12 Suppression: 22.0 %
SILDENAFIL CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12 Pc: 87000000.0 cm s-1
POLAPREZINC NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O KA: 1.3 uM
TRIMETHOPRIM COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC IC50: 12000.0 nM
ESTRADIOL C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O IC50: 1.5 nM
TAMOXIFEN CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1 IC50: 6750.0 nM
ESTRONE C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O EC50: 1135.0 nM
PYRIMETHAMINE CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1 IC50: 2800.0 nM
DIPYRIDAMOLE OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1 IC50: 500.0 nM

Top Fragments

SMILES Avg pKi Count Structure
[5*]N[5*] 6.86 184
[3*]O[3*] 6.5 160
[16*]c1ccc([16*])cc1 8.08 132
[16*]c1ccc(O)cc1 6.89 105
[4*]C[8*] 6.6 98